Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Export

@article{citeulike:1097302, abstract = {OBJECTIVES: To present the data supporting the possible relationship of ocular toxoplasmosis to antitumor necrosis factor-alpha (TNF-alpha) therapy in patients with rheumatoid arthritis (RA). METHODS: A Medline search was performed using the words "toxoplasmosis, anti-TNF-alpha antagonists, chorioretinitis." We report 2 RA patients who developed ocular toxoplasmosis while receiving anti-TNF-alpha therapy. RESULTS: In addition to our patients with toxoplasmic chorioretinitis, there are 2 published cases of cerebral toxoplasmosis during treatment with anti-TNF-alpha agents. CONCLUSION: The risk of serious toxoplasmic infection during anti-TNF-alpha therapy for RA should be recognized.}, address = {Service de Rhumatologie, Centre Hospitalier, Cahors, France.}, author = {Lassoued, S. and Zabraniecki, L. and Marin, F. and Billey, T.}, citeulike-article-id = {1097302}, citeulike-linkout-0 = {http://dx.doi.org/10.1016/j.semarthrit.2006.08.004}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/17067660}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=17067660}, doi = {10.1016/j.semarthrit.2006.08.004}, issn = {0049-0172}, journal = {Semin Arthritis Rheum}, keywords = {antitumor, eye, factor, necrosis, ocular, toxoplasmosis}, month = {February}, number = {4}, pages = {262--263}, posted-at = {2007-02-09 19:22:28}, priority = {4}, title = {Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis.}, url = {http://dx.doi.org/10.1016/j.semarthrit.2006.08.004}, volume = {36}, year = {2007} }

TY - JOUR ID - citeulike:1097302 L3 - citeulike-article-id:1097302 N2 - OBJECTIVES: To present the data supporting the possible relationship of ocular toxoplasmosis to antitumor necrosis factor-alpha (TNF-alpha) therapy in patients with rheumatoid arthritis (RA). METHODS: A Medline search was performed using the words "toxoplasmosis, anti-TNF-alpha antagonists, chorioretinitis." We report 2 RA patients who developed ocular toxoplasmosis while receiving anti-TNF-alpha therapy. RESULTS: In addition to our patients with toxoplasmic chorioretinitis, there are 2 published cases of cerebral toxoplasmosis during treatment with anti-TNF-alpha agents. CONCLUSION: The risk of serious toxoplasmic infection during anti-TNF-alpha therapy for RA should be recognized. IS - 4 JF - Semin Arthritis Rheum SN - 0049-0172 AD - Service de Rhumatologie, Centre Hospitalier, Cahors, France. EP - 263 TI - Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. VL - 36 SP - 262 KW - antitumor KW - eye KW - factor KW - necrosis KW - ocular KW - toxoplasmosis AU - Lassoued, S AU - Zabraniecki, L AU - Marin, F AU - Billey, T PY - 2007/02// UR - http://dx.doi.org/10.1016/j.semarthrit.2006.08.004 ER -